Toggle NavigationHomeRecent ProjectsServicesOur ClientsContactHomeRecent ProjectsServicesOur ClientsContact MILLER ECONOMICS Payer Matters in Development | Dossiers | Market In Development Odomzo® (Sun Pharma) - BCCLorbrena® (Pfizer) - NSCLCVizimpro® (Pfizer) - NSCLCKisqali® (Novartis) - aBCPiqray® (Novartis) - aBCDarzalex® (Janssen) - MMResiquimod® (Galderma) - CTCLNerlynx® (Puma) - aBCOlumiant® (Lilly) - RAEtrasimod® (Arena) - UCSunosi® (Jazz) - EDSBempedoic Acid (D-S) - CVAbicipar® (Allergan) - wAMD In Dossiers Erleada® (Janssen) - nmCRPCVenclexta® (AbbVie) - CLLXospata® (Astellas) - AMLBavencio® (Pfizer/Merck) - aRCCLynparza® (AZ) - aOCImfinzi® (AZ) - NSCLCTagrisso® (AZ) - NSCLCPolivy® (Roche) - DLBCLJorveza® (Dr Falk) - GIRinvoq® (AbbVie) - RAVeltassa® (Vifor) - hyperkalemiaAlofisel® (Takeda) - CDCrysvita® (KKI) - XLH In Market Zolgensma® (AveXis) - SMADupixent® (Sanofi) - AD, +Penthrox® (Galen) - trauma painAirsonett® Air (Airsonett) - allergic asthma, eczema [device]Innovative contracting (Vertex) / PreviousNextPausePlayClose